SWEAT TESTING FOR HEROIN, COCAINE, AND METABOLITES

被引:110
作者
CONE, EJ
HILLSGROVE, MJ
JENKINS, AJ
KEENAN, RM
DARWIN, WD
机构
[1] Addiction Research Center, National Institute on Drug Abuse, Baltimore, MD, 21224
关键词
D O I
10.1093/jat/18.6.298
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Although a variety of drugs have been detected in sweat, little information is available on the characteristics of drug excretion in sweat under controlled-dosing conditions. A series of clinical studies were designed to determine the identity, concentration, time course, dose dependency, and variability of drug and metabolite excretion in sweat following administration of single doses of cocaine and heroin to human subjects. Sweat was collected by means of a sweat patch that could be worn for a period of several days to several weeks at a time, resulting in accumulation of drug in the patch. Sweat patches were removed at specified times and frozen until analyzed by gas chromatographymass spectrometry. Cocaine and heroin were the major analytes excreted in sweat following their administration. Smaller amounts of cocaine metabolites were also detected following cocaine administration. 6-Acetylmorphine appeared rapidly after heroin administration and continued to increase while heroin content decreased, suggesting that heroin was undergoing hydrolysis in the sweat patch. Cocaine appeared in sweat within 1-2 hours and peaked within 24 hours in an apparent dose-dependent manner. Analysis of duplicate adjacent patches from individual subjects who had been administered cocaine provided similar quantitative results, suggesting that intrasubject variability was relatively low, whereas intersubject variability was high. These observations regarding the excretion of cocaine and heroin analytes in sweat have important forensic implications to other fields such as hair analysis. Sweat excretion could be an important mechanism by which drugs enter hair. These data also suggest that the sweat patch could serve as a useful monitoring device in surveillance of individuals in treatment and probation programs. © 1994, Oxford University Press.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 20 条
  • [1] Balabanova S., 1989, LABORATORIUMSMEDIZIN, V13, P479
  • [2] BROWN DJ, 1985, METHOD FIND EXP CLIN, V7, P539
  • [3] BRUSILOW SW, 1967, AM J PHYSIOL, V214, P513
  • [4] SALIVA TESTING FOR DRUGS OF ABUSE
    CONE, EJ
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 694 : 91 - 127
  • [5] COOK CE, 1982, CLIN PHARMACOL THER, V31, P625
  • [6] EICHNA LW, 1945, B JOHNS HOPKINS HOSP, V76, P25
  • [7] GOLDBERGER BA, 1993, CLIN CHEM, V39, P670
  • [8] GORODETZKY CW, 1974, CLIN PHARMACOL THER, V15, P579
  • [9] HENDERSON GL, 1973, RES COMMUN CHEM PATH, V5, P1
  • [10] SIGNIFICANCE OF DRUG ANALYSIS OF SWEAT IN RESPECT TO RAPID SCREENING FOR DRUG-ABUSE
    ISHIYAMA, I
    NAGAI, T
    NAGAI, T
    KOMURO, E
    MOMOSE, T
    AKIMORI, N
    [J]. ZEITSCHRIFT FUR RECHTSMEDIZIN-JOURNAL OF LEGAL MEDICINE, 1979, 82 (04): : 251 - 256